{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T19:09:51Z","timestamp":1790104191742,"version":"4.0.1"},"reference-count":29,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T00:00:00Z","timestamp":1653955200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Journal of Medical Virology"],"published-print":{"date-parts":[[2022,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Gene therapy using an adeno\u2010associated virus (AAV) vector offers a new treatment option for individuals with monogenetic disorders. The major bottleneck is the presence of pre\u2010existing anti\u2010AAV antibodies, which impacts its use. Even very low titers of neutralizing antibodies (NAb) to capsids from natural AAV infections have been reported to inhibit the transduction of intravenously administered AAV in animal models and are associated with limited efficacy in human trials. Assessing the level of pre\u2010existing NAb is important for determining the primary eligibility of patients for AAV vector\u2010based gene therapy clinical trials. Techniques used to screen AAV\u2010antibodies include AAV capsid enzyme\u2010linked immunosorbent assay\u00a0(ELISA) and transduction inhibition assay (TIA) for detecting total capsid\u2010binding (TAb) and Nab, respectively. In this study, we screened 521 individuals with hemophilia A from India for TAb and NAb using ELISA and TIA, respectively. The prevalence of TAb and NAb in hemophilia A patients from India were 96% and 77.5%, respectively. There was a significant increase in anti\u2010AAV3 NAb prevalence with age in the hemophilia A patient group from India. There was a trend in anti\u2010AAV3 TAb positivity between the pediatric age group (94.4%) and the adult age group (97.4%).<\/jats:p>","DOI":"10.1002\/jmv.27859","type":"journal-article","created":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T01:47:42Z","timestamp":1652752062000},"page":"4542-4547","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Age\u2010stratified adeno\u2010associated virus serotype 3 neutralizing and total antibody prevalence in hemophilia A patients from India"],"prefix":"10.1002","volume":"94","author":[{"given":"Hubert D.\u2010J","family":"Daniel","sequence":"first","affiliation":[{"name":"Center for Stem Cell Research Christian Medical College  Vellore India"},{"name":"Department of Clinical Virology Christian Medical College  Vellore India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Kumar","sequence":"additional","affiliation":[{"name":"Center for Stem Cell Research Christian Medical College  Vellore India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Kannangai","sequence":"additional","affiliation":[{"name":"Department of Clinical Virology Christian Medical College  Vellore India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farzana","family":"J.","sequence":"additional","affiliation":[{"name":"Center for Stem Cell Research Christian Medical College  Vellore India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph N.","family":"Joel","sequence":"additional","affiliation":[{"name":"Center for Stem Cell Research Christian Medical College  Vellore India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aby","family":"Abraham","sequence":"additional","affiliation":[{"name":"Department of Hematology Christian Medical College  Vellore India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kavitha M.","family":"Lakshmi","sequence":"additional","affiliation":[{"name":"Department of Hematology Christian Medical College  Vellore India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mavis","family":"Agbandje\u2010McKenna","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology University of Florida  Gainesville Florida USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten E.","family":"Coleman","sequence":"additional","affiliation":[{"name":"Powell Gene Therapy Center Toxicology Core University of Florida  Gainesville Florida USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun","family":"Srivastava","sequence":"additional","affiliation":[{"name":"Department of Pediatrics University of Florida  Gainesville Florida USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alok","family":"Srivastava","sequence":"additional","affiliation":[{"name":"Center for Stem Cell Research Christian Medical College  Vellore India"},{"name":"Department of Hematology Christian Medical College  Vellore India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asha M.","family":"Abraham","sequence":"additional","affiliation":[{"name":"Center for Stem Cell Research Christian Medical College  Vellore India"},{"name":"Department of Clinical Virology Christian Medical College  Vellore India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2022,5,31]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2018.234"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2004.10.012"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1996.0367"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-61779-370-7_3"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.coviro.2016.08.003"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2016.160"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2016.61"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature12875"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.035113-0"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2009.182"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1086\/595830"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2095-4964(15)60200-X"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9071(199911)59:3<406::AID-JMV22>3.0.CO;2-N"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2020.099"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2020.258"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtm.2018.02.003"},{"issue":"85","key":"e_1_2_9_18_1","first-page":"379","article-title":"Humoral immunity to AAV vectors in gene therapy: challenges and potential solutions","volume":"15","author":"Masat E","year":"2013","journal-title":"Discov Med"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/gt.2017.95"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.71.2.1341-1352.1997"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/gt.2014.103"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3300994"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.23818"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1089\/hgtb.2015.037"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.05107-11"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtm.2019.05.009"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41556-020-0563-3"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-0911-7"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.139881"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00675-12"}],"container-title":["Journal of Medical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jmv.27859","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/jmv.27859","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jmv.27859","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T07:29:22Z","timestamp":1692775762000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jmv.27859"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,31]]},"references-count":29,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["10.1002\/jmv.27859"],"URL":"https:\/\/doi.org\/10.1002\/jmv.27859","archive":["Portico"],"relation":{},"ISSN":["0146-6615","1096-9071"],"issn-type":[{"value":"0146-6615","type":"print"},{"value":"1096-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,31]]},"assertion":[{"value":"2021-12-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-11","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-31","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}